Cardiome Pharma Corporation Debt to Equity Ratio 2016-2019 | CORV
Current and historical debt to equity ratio values for Cardiome Pharma Corporation (CORV) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Cardiome Pharma Corporation debt/equity for the three months ending September 30, 2019 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2019-09-30 | $0.06B | $0.00B | 37.60 |
| 2019-06-30 | $0.06B | $0.00B | -270.49 |
| 2019-03-31 | $0.06B | $0.01B | 9.34 |
| 2018-12-31 | $0.05B | $0.01B | 7.63 |
| 2018-09-30 | $0.05B | $0.01B | 5.12 |
| 2018-06-30 | $0.05B | $0.02B | 3.51 |
| 2018-03-31 | $0.05B | $0.01B | 5.50 |
| 2017-12-31 | $0.05B | $0.02B | 3.13 |
| 2017-09-30 | $0.05B | $0.02B | 2.13 |
| 2017-06-30 | $0.04B | $0.03B | 1.40 |
| 2017-03-31 | $0.03B | $0.03B | 1.13 |
| 2016-12-31 | $0.03B | $0.03B | 0.97 |
| 2016-09-30 | $0.03B | $0.04B | 0.81 |
| 2016-06-30 | $0.04B | $0.01B | 3.48 |
| 2016-03-31 | $0.03B | $0.02B | 1.26 |
| 2015-12-31 | $0.03B | $0.02B | 1.42 |
| 2015-09-30 | $0.00B | 0.00 | |
| 2015-06-30 | $0.00B | 0.00 | |
| 2015-03-31 | $0.00B | 0.00 | |
